Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19

Ann Pharmacother. 2023 Jan;57(1):110-112. doi: 10.1177/10600280221096883. Epub 2022 May 18.

Authors

Da Woon Sim¹, Eun Myoung¹, Son Hoyoung¹

Affiliation

¹ Department of Allergy and Clinical Immunology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, South Korea.

No abstract available

Keywords: COVID-19; adverse reaction; desensitization; remdesivir; urticaria.

Publication types

Letter

MeSH terms

COVID-19 Drug Treatment*
Desensitization, Immunologic
Drug Hypersensitivity* / etiology
Drug Hypersensitivity* / therapy
Humans
Hypersensitivity*